Skip to content

Outcomes of Partial Pulpotomy Treatment in Cariously Exposed Teeth

Treatment Outcomes of Partial Pulpotomy Using Two Different Calcium Silicate Materials in Cariously Exposed Mature Permanent Teeth: A Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06802549
Enrollment
61
Registered
2025-01-31
Start date
2024-03-20
Completion date
2025-06-20
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Dental Caries

Keywords

deep dental caries, partial pulpotomy, calcium silicate-based material

Brief summary

The aim of this clinical trial is to learn how successful Biodentine and Theracal PT dental filling materials are in treating deep tooth decay in adults. It will also provide information about post-treatment pain. The main questions it aims to answer are: Do Biodentine and Theracal PT dental filling materials treat exposed tooth decay in participants? Do they reduce the need for root canal treatment? After the application of Biodentine and Theracal PT dental filling materials to the participants, the pain and symptoms that cause pain may not decrease. In this case, the tooth may be treated with root canal treatment. The researchers will compare the clinical success of Biodentine and Theracal PT dental filling materials with each other. Participants will undergo a single-session partial pulpotomy treatment with the dental filling materials mentioned above. Clinical and radiographic follow-ups will then be performed at 3, 6 and 12 months, and records will be kept.

Interventions

It will be placed on the exposed pulp with the help of a carrier and the exposed pulp will be covered with material

DEVICETheracal PT (resin modified calcium silicate-based cement) (Bisco Inc., Schaumburg, IL, USA)

It will be placed on the exposed pulp with the help of its injection tip and the exposed pulp will be covered with material

Sponsors

Firat University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

statistician

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* • Patient age should be between 18-50 years * Should be able to give written informed consent * Should have systemic status (ASA 1) * Should have permanent molar or premolar (lower and upper) root development * Should be asymptomatic, deep (D3) or extremely deep (D4) caries * Should give vital response in cold test and electric pulp test * Should have teeth where the pulp is exposed with caries * Should not have pain during palpation and percussion * Should not have periodontal disease * Should have restorable teeth * Should have teeth without pulp necrosis, sinus tract or swelling/abscess * Should have bleeding time less than 10 minutes * Should be able to include a maximum of two teeth in a patient in the study (should be in different quadrants and there should be at least 2 weeks between treatment periods)

Exclusion criteria

* Teeth with incomplete root development * Severely affected teeth that do not respond to pulp sensitivity tests * Teeth with signs and symptoms of irreversible pulpitis * Teeth without signs of bleeding after communicating with the pulp chamber * Teeth with pulp chamber open to the oral environment * Teeth with periodontal pockets greater than 4 mm deep * Teeth with suspected cracks or crown fractures that may be responsible for pulp pathology * Teeth with uncontrolled bleeding * Medically at-risk patients will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Tooth survival. Both clinical and radiographic healing means Tooth survival. Clinical healing; absence of clinical symptoms. Radiographic healing; absence of emerging periapical radiolucency.From enrollment to the end of treatment at 1 year

Secondary

MeasureTime frame
Post operative pain. It will be evaluated with a 10-unit visual analog scale. 0: no pain, 1-3 mild pain, 4-6 moderate-severe pain, 7-9 very severe pain, 10 worst pain.From enrollment to the follow up at 1 week, 3,6.12 months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026